Showing 1 - 20 results of 20 for search 'Johanna G. van derBom', query time: 0.06s
Refine Results
-
1
Thromboembolic events in severe postpartum hemorrhage treated with recombinant activated factor VII: a systematic literature review and meta-analysis by Johanna G. van der Bom, Frédéric J. Mercier, Damaris Bausch-Fluck, Mads Nordentoft, Morten Medici, Rezan Abdul-Kadir
Published 2024-07-01
Article -
2
Prediction of Inhospital Mortality in Critically Ill Patients With Sepsis: Confirmation of the Added Value of 24-Hour Lactate to Acute Physiology and Chronic Health Evaluation IV by Meryem Baysan, MD, Mendi S. Arbous, MD, PhD, Ewout W. Steyerberg, MD, PhD, Johanna G. van der Bom, MD, PhD
Published 2022-09-01
Article -
3
The effect of a fibrin sealant on knee function after total knee replacement surgery. Results from the FIRST trial. A multicenter randomized controlled trial. by Wiebe C Verra, Joost A van Hilten, Áine Honohan, Erik W van Zwet, Johanna G van der Bom, Rob G H H Nelissen, FIRST-research group
Published 2018-01-01
Article -
4
-
5
-
6
Desmopressin in moderate hemophilia A patients: a treatment worth considering by Janneke I. Loomans, Marieke J.H.A. Kruip, Manuel Carcao, Shannon Jackson, Alice S. van Velzen, Marjolein Peters, Elena Santagostino, Helen Platokouki, Erik Beckers, Jan Voorberg, Johanna G. van der Bom, Karin Fijnvandraat, for the RISE consortium
Published 2018-03-01
Article -
7
Absence of the spleen and the occurrence of primary red cell alloimmunization in humans by Dorothea Evers, Johanna G. van der Bom, Janneke Tijmensen, Masja de Haas, Rutger A. Middelburg, Karen M.K. de Vooght, Daan van de Kerkhof, Otto Visser, Nathalie C.V. Péquériaux, Francisca Hudig, Jaap Jan Zwaginga
Published 2017-08-01
Article -
8
Treatments for hematologic malignancies in contrast to those for solid cancers are associated with reduced red cell alloimmunization by Dorothea Evers, Jaap Jan Zwaginga, Janneke Tijmensen, Rutger A. Middelburg, Masja de Haas, Karen M.K. de Vooght, Daan van de Kerkhof, Otto Visser, Nathalie C.V. Péquériaux, Francisca Hudig, Johanna G. van der Bom
Published 2017-01-01
Article -
9
Toward Personalized Care and Patient Empowerment and Perspectives on a Personal Health Record in Hemophilia Care: Qualitative Interview Study by Martijn R Brands, Lotte Haverman, Jelmer J Muis, Mariëtte H E Driessens, Stephan Meijer, Felix J M van der Meer, Marianne de Jong, Johanna G van der Bom, Marjon H Cnossen, Karin Fijnvandraat, Samantha C Gouw
Published 2024-09-01
Article -
10
Association between fluid management and dilutional coagulopathy in severe postpartum haemorrhage: a nationwide retrospective cohort study by Ada Gillissen, Thomas van den Akker, Camila Caram-Deelder, Dacia D C A Henriquez, Kitty W M Bloemenkamp, Jos J M van Roosmalen, Jeroen Eikenboom, Johanna G van der Bom, on behalf of the TeMpOH-1 study group
Published 2018-10-01
Article -
11
Dynamic prediction of bleeding risk in thrombocytopenic preterm neonates by Susanna F. Fustolo-Gunnink, Karin Fijnvandraat, Hein Putter, Isabelle M. Ree, Camila Caram-Deelder, Peter Andriessen, Esther J. d’Haens, Christian V. Hulzebos, Wes Onland, André A. Kroon, Daniël C. Vijlbrief, Enrico Lopriore, Johanna G. van der Bom
Published 2019-11-01
Article -
12
Transfusion of ever-pregnant donor red blood cells and mortality of male patients by Sarah J. Valk, Camila Caram-Deelder, Rolf. H.H. Groenwold, Dorothea Evers, Karen M.K. de Vooght, Daan van de Kerkhof, Marielle J Wondergem, Nathalie C.V. Péquériaux, Francisca Hudig, Jaap Jan Zwaginga, Rutger A. Middelburg, Johanna G. van der Bom
Published 2024-02-01
Article -
13
Transition from fresh frozen plasma to solvent/detergent plasma in the Netherlands: comparing clinical use and transfusion reaction risks by Nicholas H. Saadah, Martin R. Schipperus, Johanna C. Wiersum-Osselton, Marian G. van Kraaij, Camila Caram-Deelder, Erik A.M. Beckers, Anja Leyte, Jan M.M. Rondeel, Karen M.K. de Vooght, Floor Weerkamp, Jaap Jan Zwaginga, Johanna G. van der Bom
Published 2020-04-01
Article -
14
Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease by Johan Boender, Ferdows Atiq, Marjon H. Cnossen, Johanna G. van der Bom, Karin Fijnvandraat, Joke de Meris, Moniek P. M. de Maat, Karin P. M. van Galen, Britta A. P. Laros-van Gorkom, Karina Meijer, Jeroen Eikenboom, Frank W. G. Leebeek, for the WiN study group*
Published 2021-03-01
Article -
15
Long-term impact of joint bleeds in von Willebrand disease: a nested case-control study by Karin P.M. van Galen, Piet de Kleijn, Wouter Foppen, Jeroen Eikenboom, Karina Meijer, Roger E.G. Schutgens, Kathelijn Fischer, Marjon H. Cnossen, Joke de Meris, Karin Fijnvandraat, Johanna G. van der Bom, Britta A.P. Laros-van Gorkom, Frank W.G. Leebeek, Eveline P. Mauser-Bunschoten
Published 2017-09-01
Article -
16
Patient‐relevant health outcomes for hemophilia care: Development of an international standard outcomes set by Erna C. vanBalen, Brian O'Mahony, Marjon H. Cnossen, Gerard Dolan, Victor S. Blanchette, Kathelijn Fischer, Deborah Gue, Jamie O'Hara, Alfonso Iorio, Shannon Jackson, Barbara A. Konkle, Diane J. Nugent, Donna Coffin, Mark W. Skinner, Cees Smit, Alok Srivastava, Fred vanEenennaam, Johanna G. van derBom, Samantha C. Gouw
Published 2021-05-01
Article -
17
Hepatitis C virus in hemophilia: Health‐related quality of life after successful treatment in the sixth Hemophilia in the Netherlands study by Cas J. Isfordink, Samantha C. Gouw, Erna C. vanBalen, Shermarke Hassan, Erik A. M. Beckers, Johanna G. van derBom, Michiel Coppens, Jeroen Eikenboom, Kathelijn Fischer, Louise Hooimeijer, Frank W. G. Leebeek, Frits R. Rosendaal, Saskia E. M. Schols, Cees Smit, Lize F. D. vanVulpen, Eveline P. Mauser‐Bunschoten
Published 2021-12-01
Article -
18
Importance of Genotyping in von Willebrand Disease to Elucidate Pathogenic Mechanisms and Variability in Phenotype by Ferdows Atiq, Johan Boender, Waander L. van Heerde, Juan M. Tellez Garcia, Selene C. Schoormans, Sandy Krouwel, Marjon H. Cnossen, Britta A. P. Laros-van Gorkom, Joke de Meris, Karin Fijnvandraat, Johanna G. van der Bom, Karina Meijer, Karin P. M. van Galen, Jeroen Eikenboom, Frank W. G. Leebeek, for the WiN Study Group*
Published 2022-06-01
Article -
19
Socioeconomic participation of persons with hemophilia: Results from the sixth hemophilia in the Netherlands study by Erna C. van Balen, Shermarke Hassan, Cees Smit, Mariette H. E. Driessens, Erik A. M. Beckers, Michiel Coppens, Jeroen C. Eikenboom, Hélène L. Hooimeijer, Frank W. G. Leebeek, Evelien P. Mauser‐Bunschoten, Lize F. D. van Vulpen, Saskia E. M. Schols, Frits R. Rosendaal, Johanna G. van der Bom, Samantha C. Gouw
Published 2022-08-01
Article -
20
The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A by Ilja Oomen, Ilja Oomen, Marieke Verhagen, Marieke Verhagen, Marieke Verhagen, Mariarosaria Miranda, Peter Allacher, Erik A. M. Beckers, Nicole M. A. Blijlevens, Nicole M. A. Blijlevens, Johanna G. van der Bom, Michiel Coppens, Mariëtte Driessens, Jeroen C. J. Eikenboom, Karin Fijnvandraat, Karin Fijnvandraat, Shermarke Hassan, Shermarke Hassan, Waander L. van Heerde, Waander L. van Heerde, Waander L. van Heerde, H. Louise Hooimeijer, Joop H. Jansen, Paul Kaijen, Frank W. G. Leebeek, Daniëlle Meijer, Helmut Paul, Sanna R. Rijpma, Frits R. Rosendaal, Cees Smit, Cees Smit, Lize F. D. van Vulpen, Jan Voorberg, Jan Voorberg, Saskia E. M. Schols, Saskia E. M. Schols, Samantha C. Gouw, Samantha C. Gouw
Published 2024-02-01
Article